The effectiveness of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 Omicron variant in immunosuppressed solid organ and islet transplant (SOT) recipients is unclear.
The original SARS-CoV-2 vaccination regimen (2 doses) induces insufficient short-term response in kidney transplant (KT) recipients. This study assessed the response to a third dose and the long-term immunogenicity after 2 doses in KT.
Targeting interleukin-6 (IL-6) was shown to counteract donor-specific antibody production and antibody-mediated rejection (AMR) activity. It is not known whether, or to what extent, IL-6 antagonism modulates biomarkers indicative of tissue damage (donor-derived cell-free DNA [dd-cfDNA]) and parenchymal inflammation (C-X-C motif chemokine ligand [CXCL] 10).
The 18th Congress of the MESOT will be an ideal opportunity to share and learn from peers and in the field. State-of-the-art lectures, plenaries, oral presentations and poster receptions will stimulate deep discussions on the latest scientific research in all fields of organ transplantation in the Middle East, Mid Asia and the world.
MESOT 2023 will be held on May 24-26, 2023 in Ankara, Turkey, and is endorsed by The Transplantation Society (TTS), The Turkish Transplantation Society (TOND) and The Turkic World Transplantation Society (TDTD).
Please note that the position on Pillar 2 has already been filled.
The missions of each Pillar are as follows:
Please send your Expression of Interest to Katie Tait at firstname.lastname@example.org.
Submission deadline: February 28, 2023
The Transplantation Society
740 Notre-Dame Ouest
Montréal, QC, H3C 3X6